GENEVA, Dec. 22 -- NOVARTIS AG (Lichtstrasse 354056 Basel) filed a patent application (PCT/IB2025/056029) for "TREATMENT OF SYSTEMIC SCLEROSIS USING ANTI-BAFF-R ANTIBODIES" on Jun 12, 2025. With publication no. WO/2025/257781, the details related to the patent application was published on Dec 18, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): D'ANDREA, Peter (Novartis Pharmaceuticals Corporation59 Route 10East Hanover, New Jersey 07936), GERGELY, Peter (Novartis Pharma AGLichtstrasse 354056 Basel)
Abstract: The disclosure relates to methods, treatment regimens, uses, kits and therapies for...